HPLC purification of adenoviral vectors

Methods in Molecular Biology

Volumn 594, Issue , 2010, Pages 395-408

  Eglon, Marc ^a   McGrath, Barry ^a   O'Brien, Timothy ^a  

^a NONE

Author keywords

Adenovirus; Anion exchange; Chromatography; Gel filtration; Gene therapy vectors

Indexed keywords

ADENOVIRUS; ARTICLE; CELL LINE; GENE VECTOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY;

ADENOVIRIDAE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENETIC VECTORS; HUMANS;

EID: 77950343951     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-411-1_28     Document Type: Article

References (21)

1. Lusky M (2005) Good manufacturing practice production of adenoviral vectors for clinical trials. Hum Gene Ther 16(3):281-291
2. Segura MM, Alba R, Bosch A, Chillon M (2008) Advances in helper-dependent adeno-viral vector research. Curr Gene Ther 8(4):222-235
3. Volpers C, Kochanek S (2004) Adenoviral vectors for gene transfer and therapy. J Gene Med 6(Suppl 1):S164-S171
4. Huyghe BG, Liu X, Sutjipto S, Sugarman BJ, Horn MT, Shepard HM et al (1995) Purifcation of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 6(11):1403-1416
5. Cooper PD (1961) The plaque assay of animal viruses. Adv Virus Res 8:319-378
6. Philipson L (1961) Adenovirus assay by the fuorescent cell-counting procedure. Virology 15:263-268
7. Nielsen LK, Smyth GK, Greenfeld PF (1992) Accuracy of the endpoint assay for virus titra-tion. Cytotechnology 8(3):231-236
8. Gueret V, Negrete-Virgen JA, Lyddiatt A, Al-Rubeai M (2002) Rapid titration of adeno-viral infectivity by fow cytometry in batch culture of infected HEK293 cells. Cytotechnology 38(1-2):87-97
9. Park MT, Lee GM (2000) Rapid titer assay of adenovirus containing green fuorescent protein gene using fow cytometric analysis. Bioprocess Eng 22(5):403-406
10. Sandhu KS, Al-Rubeai M (2008) Monitoring of the adenovirus production process by fow cytometry. Biotechnol Prog 24(1):250-261
11. Nadeau I, Jacob D, Perrier M, Kamen A (2000) 293SF metabolic fux analysis during cell growth and infection with an adenoviral vector. Biotechnol Prog 16(5):872-884
12. ARMWG (2001) BRMAC meeting #30: Adenovirus titer measurements and RCA levels. FDA
13. Maizel JV Jr, White DO, Scharff MD (1968) The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36(1):115-125
14. Murakami P, McCaman MT (1999) Quantitation of adenovirus DNA and virus particles with the PicoGreen fuorescent dye. Anal Biochem 274(2):283-288
15. Kuhn I, Larsen B, Gross C, Hermiston T (2007) High-performance liquid chroma-tography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype. Gene Ther 14(2):180-184
16. Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG et al (1997) Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 8(4):453-465
17. Duffy AM, McMahon JM, O'Brien T. (2009) Generation of Anti-Oxidant Adenovirus Gene Transfer Vectors Encoding CuZnSOD, MnSOD and Catalase. Meth Mol Biol, Humana Press, NY, in press
18. Zhang WW, Koch PE, Roth JA (1995) Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18(3):444-446
19. Rexroad J, Wiethoff CM, Green AP, Kierstead TD, Scott MO, Middaugh CR (2003) Structural stability of adenovirus type 5. J Pharm Sci 92(3):665-678
20. Blanche F, Monegier B, Faucher D, Duchesne M, Audhuy F, Barbot A et al (2001) Polypeptide composition of an adenovirus type 5 used in cancer gene therapy. J Chromatogr A 921(1):39-48
21. Rux JJ, Kuser PR, Burnett RM (2003) Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 77(17):9553-9566